Dr. Indrajit Sahu is a Protein Biochemist and Molecular-cell Biologist. He has been working in the field of Ubiquitin-Proteasome-System (UPS) for the last 12 years. His research mainly focuses on protein homeostasis in human diseases and development. After finishing his PhD in Cancer biology at Advanced centre for Treatment, Research and Education in Cancer (ACTREC)-Tata Memorial Centre, Navi Mumbai he joined Prof. Michael Glickman at Technion-Israel Institute of Technology, Haifa, for his first Postdoctoral research in Ubiquitin-Proteasome biology. During his tenure at Technion he received three prestigious Postdoc fellowships (Marie-Curie Individual Fellowship, EU; FEBS short-term Fellowship, EU; and Daniel-Turnburg/ Welcome trust short-term Fellowships, UK). In 2021 he joined Prof. Alfered Goldberg at Harvard Medical School to continue his research on UPS. Thereafter in 2022 he worked with Prof. Jarrod Marto & Prof. Sara Buhrlage at Dana-Farber Cancer Institute, HMS to learn small molecule based-drug discovery against deubiquitinase enzymes for cancer.
CAMPUS: Medical Research Centre, Medicine & Health Sciences, Kattankulathur - Chennai